fbpx
Subscribe
Generic selectors
Exact matches only
Search in title
Search in content
Post Type Selectors

Archive

Individuals with osteoarthritis are commonly prescribed NSAIDs despite having contraindications

Written by | 1 Aug 2024

Osteoarthritis affects 600 million people worldwide, making it a leading cause of disability. With no disease-modifying treatments available or on the horizon, oral non-steroidal anti-inflammatory drugs (NSAIDs) are… read more.

New hope to treat and reverse osteoarthritis

Written by | 5 Nov 2023

Current osteoarthritis treatment manages symptoms rather than addressing the underlying disease, but a new University of Adelaide study has shown the condition may be treatable and reversible. Osteoarthritis… read more.

New study reveals the most common form of arthritis, osteoarthritis, affects 15% of the global population over the age of 30

Written by | 26 Aug 2023

A new study projects nearly 1 billion people will be living with osteoarthritis, the most common form of arthritis, by 2050. Currently, 15% of individuals aged 30 and… read more.

Joint disease: New therapeutic approach for osteoarthritis discovered

Written by | 4 Jul 2023

Osteoarthritis was long considered to be the result of wear and tear in advanced age. In the meantime, more and more studies are linking the degradation of articular… read more.

New study questions the efficacy of many osteoarthritis treatments

Written by | 29 Apr 2023

Recruiting osteoarthritis patients with a lot of pain to clinical studies, may give incorrect results if the researcher does account for the natural variation in pain that occurs…. read more.

Allergic (atopic) asthma/eczema linked to heightened risk of osteoarthritis

Written by | 30 Mar 2023

People with atopic (allergic) diseases like asthma or eczema may be at heightened risk of the painful and often disabling joint condition, osteoarthritis, finds research published online in… read more.

Non-surgical treatment significantly reduces knee pain for adults, especially those 50 and older

Written by | 4 Mar 2023

Genicular nerve radiofrequency ablation is a minimally invasive treatment for knee pain due to osteoarthritis of the knee, and can significantly reduce pain, especially for adults who are… read more.

New blood test is more accurate in identifying osteoarthritis progression

Written by | 28 Jan 2023

A new blood test that can identify progression of osteoarthritis in the knee is more accurate than current methods, providing an important tool to advance research and speed… read more.

Older knee replacements as good as newer models, study shows

Written by | 10 Jan 2023

Older knee replacement designs are just as effective as newer models – according to new research from the Norfolk and Norwich University Hospital and University of East Anglia…. read more.

Metformin reduces risk of joint replacement in diabetes patients

Written by | 19 Dec 2022

Metformin use appears to lower the risk of total joint replacement in patients with type 2 diabetes. Researchers reported this finding on December 19, 2022 in the CMAJ/Canadian… read more.

Quarter of former Olympians suffer from osteoarthritis

Written by | 29 Nov 2022

One in four retired Olympians reported a diagnosis of osteoarthritis, the form of arthritis that causes changes in the joint and can lead to discomfort, pain and disability,… read more.

Trial shows benefits of two forms of ankle surgery for osteoarthritis

Written by | 20 Nov 2022

Patients with advanced ankle osteoarthritis who undergo surgery see equally good outcomes from the two main surgical treatments for osteoarthritis, a new study led by UCL researchers has… read more.

Newsletter Icon

Subscribe for our mailing list

If you're a healthcare professional you can sign up to our mailing list to receive high quality medical, pharmaceutical and healthcare E-Mails and E-Journals. Get the latest news and information across a broad range of specialities delivered straight to your inbox.

Subscribe

You can unsubscribe at any time using the 'Unsubscribe' link at the bottom of all our E-Mails, E-Journals and publications.